Aseptic, isolator‑based fill‑finish spans multiple formats and batch sizes, supported by onsite analytics that cut hand‑offs and streamline testing. Learn how this setup boosts efficiency.
A U.S.-based sterile injectable CDMO delivering scalable small and large molecule manufacturing, supported by advanced aseptic technologies and integrated quality systems.
Global partner delivering end‑to‑end drug development, manufacturing, and packaging with deep expertise, advanced facilities, and support across key modalities.
Nanomilling revolutionizes drug delivery by reducing particle size to enhance solubility, bioavailability, and therapeutic efficacy, addressing the challenges of poorly water-soluble APIs.
Uncover how comprehensive drug product fill and finish services streamline the journey from formulation development to commercialization, ensuring quality, efficiency, and compliance.
A unified global model streamlines biologics from discovery to commercial supply, integrating development, manufacturing, advanced modalities, and flexible partnerships worldwide.
